Yi Liang
Keine laufenden Positionen mehr
Profil
Yi Liang served as Vice President-Oncology at Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd.
and Vice President at AstraZeneca Pharmaceuticals Co., Ltd.
Prior to that, he was the Chief Commercial Officer & President-Greater China at Zai Lab Ltd.
from 2018 to 2024.
Dr. Liang holds an MBA from China Europe International Business School and a doctorate from Fudan University.
Ehemalige bekannte Positionen von Yi Liang
| Unternehmen | Position | Ende |
|---|---|---|
| ZAI LAB LIMITED | Corporate Officer/Principal | 30.04.2024 |
| Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. | Corporate Officer/Principal | - |
AstraZeneca Pharmaceuticals Co., Ltd.
 AstraZeneca Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Pharmaceutical Co., Ltd. is a Chinese global biopharmaceutical company driven by innovation. Based in Shanghai, China. The private company believes in the power of science and considers it a top priority in all of its work. | Corporate Officer/Principal | - |
Ausbildung von Yi Liang
| China Europe International Business School | Masters Business Admin |
| Fudan University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ZAI LAB LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. | |
AstraZeneca Pharmaceuticals Co., Ltd.
AstraZeneca Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Pharmaceutical Co., Ltd. is a Chinese global biopharmaceutical company driven by innovation. Based in Shanghai, China. The private company believes in the power of science and considers it a top priority in all of its work. | Health Technology |
